Escherichia coli and Klebsiella pneumoniae carbapenemase in long-term care facility, Illinois, USA

Emerging Infectious Diseases

Volumn 15, Issue 6, 2009, Pages 988-989

  McGuinn, Marcella ^a,b   Hershow, Ronald C ^a   Janda, William M ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CARBAPENEMASE; COTRIFAMOLE; GENTAMICIN; NITROFURANTOIN; PIPERACILLIN PLUS TAZOBACTAM; TIGECYCLINE; TOBRAMYCIN;

AGED; ANTIBIOTIC RESISTANCE; BACTERIAL GENE; BACTERIAL GROWTH; BLAKPC GENE; CASE REPORT; CLINICAL FEATURE; DISEASE PREDISPOSITION; ESCHERICHIA COLI INFECTION; FEMALE; FOLLOW UP; HEALTH CARE FACILITY; HUMAN; KLEBSIELLA PNEUMONIAE INFECTION; LETTER; LONG TERM CARE; POLYMERASE CHAIN REACTION; TREATMENT DURATION; URINALYSIS;

AGED; BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; ILLINOIS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; LONG-TERM CARE; POLYMERASE CHAIN REACTION; TREATMENT OUTCOME; URINARY TRACT INFECTIONS; URINE;

EID: 67449086647     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1506.081735     Document Type: Letter

References (7)

1. Navon-Venezia S, Chmelnitsky I, Leavitt A, Schwaber M, Schwartz D, Carmeli Y. Plasmid-mediated imipenem-hydrolyzing enzyme KPC-2 among multiple carbapenem-resistant Escherichia coli clones in Israel. Antimicrob Agents Chemother. 2006;50:3098-3101 DOI: 10.1128/AAC.00438-06
2. Cai JC, Zhou HW, Zhang R, Chen GX. Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli isolates possessing the plasmid-mediated carbapenem-hydrolyzing β-lactamase KPC-2 in intensive care units of Chinese hospital. Antimicrob Agents Chemother. 2008;52:2014-2018 DOI: 10.1128/AAC.01539-07
3. Hong T, Moland ES, Abdalhamid B, Hanson ND, Wang J, Sloan C, et al. E. coli producing KPC-3 carapenem hydrolyzing enzyme. In: Program and abstracts of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (Chicago). Washington: American Society for Microbiology; 2003. p. 75. Abstract C1-265.
4. Deshpande LM, Rhomberg PR, Sader HS, Jones RN. Emergence of serine carbapenemases (KPC and SME) among clinical strains of Enterobacteriaceae isolated in the United States Medical Centers: Report from the MYSTIC Program (1999-2005). Diagn Microbiol Infect Dis. 2006;56:367-372 DOI: 10.1016/j.diagmicrobio.2006.07.004
5. Bratu S, Brooks S, Burney S, Kochar S, Gupta J, Landman D, et al. Detection and spread of Escherichia coli possessing the plasmid-borne carbapenemase KPC-2 in Brooklyn, New York. Clin Infect Dis. 2007;44:972-975 DOI: 10.1086/512370
6. Urban C, Bradford PA, Tuckman M, Segal-Maurer S, Wehbeh W, Grenner L, et al. Carbapenem-resistant Escherichia coli harboring Klebsiella pneumoniae carbapenemase β-lactamases associated with long-term care facilities. Clin Infect Dis. 2008;46:e127-30. DOI: 10.1086/588048
7. Anderson KF, Lonsway DR, Rasheed JK, Biddle J, Jensen B, McDougal LK, et al. Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae. J Clin Microbiol. 2007;45:2723-2725 DOI: 10.1128/JCM.00015-07 (Pubitemid 47295515)